SCHEMBL2975901

SCHEMBL2975901

C=CCN(CC=C)Cc1cccn1C

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 1/20 0.38
HSD11B1 P28845 2/20 0.38
CYP3A4 P08684 2/20 0.38
TRPM8 Q7Z2W7 1/20 0.35
PYCR1 P32322 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP2C19 P33261 2/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 2/20 0.33
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
PKM P14618 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
RECQL P46063 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973791 0.77 TRPM8 (0.44) ALDH1A1HSD11B1CYP3A4TRPM8MEN1
SCHEMBL4889420 0.75
SCHEMBL385866 0.72 HSD11B1 (0.46) ALDH1A1HSD11B1CYP3A4TRPM8MEN1
SCHEMBL16708778 0.69 HSD11B1 (0.44) ALDH1A1HSD11B1CYP3A4TRPM8MEN1
SCHEMBL2977082 0.68 CYP3A4 (0.47) ALDH1A1LMNACYP3A4PYCR1CYP2C19
SCHEMBL11667015 0.68 ALDH1A1 (0.56) ALDH1A1LMNAHTTCYP3A4PYCR1
SCHEMBL18254049 0.68
SCHEMBL4263885 0.68
SCHEMBL10103709 0.67 MEN1 (0.44) ALDH1A1LMNACYP3A4MEN1KMT2A
SCHEMBL11137339 0.65 PYCR1 (0.55) ALDH1A1LMNAHTTPYCR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4374256-A CONTROLLING THE RATE OF FEED OF THE QUATERNARY SALT TO HOT AQUEOUS ALKALI CYNIDE AND WATER-IMMISCIBLE SOLVENT ETHYL CORPORATION (US) 1983-02-15 US claimed
US-7776903-B2 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2010-08-17 US disclosed
EP-1578416-B1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES GRUENENTHAL GMBH (DE) 2006-08-02 EP disclosed
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles GRUENENTHAL GMBH (DE) 2005-12-08 US disclosed
EP-1578416-A1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES Grünenthal GmbH (DE) 2005-09-28 EP disclosed
WO-2004058248-A1 MEDICAMENTS CONTAINING SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLES Grünenthal GmbH (DE) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272782-A1 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles THPO, ADCYAP1R1, DPYD ALDH1A1 327/4885LMNA 3851/4885HTT 1606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.